17-(3-Pyridinyl)-androst-4-en-3-one
| Product Name |
17-(3-Pyridinyl)-androst-4-en-3-one
|
| Product Code |
DA-A007-10
|
| Chemical name |
17-(3-Pyridinyl)-androst-4-en-3-one
|
| Synonyms |
(8S,9S,10R,13S,14S)-10,13-Dimethyl-17-(pyridin-3-yl)-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one;
|
| Impurity |
NA
|
| CAS Number |
1382474-09-0
|
| Alternate CAS # |
NA
|
| Molecular form |
C24H31NO
|
| Appearance |
NA
|
| Melting Point |
NA
|
| Mol. Weight |
349.52
|
| Storage |
2-8°C Refrigerator
|
| Solubility |
NA
|
| Stability |
NA
|
| Category |
impurities,metabolites,pharmaceutical standards,intermediates,fine chemicals
|
| Boiling Point |
NA
|
| Applications |
17-(3-Pyridinyl)-androst-4-en-3-one is an impurity of Abiraterone a steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor , is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent prostate cancer. (3-Keto Abiraterone Impurity 1).
|
| Dangerous Goods Info |
NA
|
| References |
NA
|
| Extra Notes |
NA
|
| Documents (MSDS) |
No Data Available
|
| Keywords |
NA |
